There is a strong association between particular genotypes of human papilloma virus (HPV) and cervical cancer. The mechanism by which HPV achieves oncogenesis is thought to be mediated by two viral oncoproteins, E6 and E7. Both these oncoproteins complex with several cellular proteins that are responsible for regulating cell growth, especially p53 and retinoblastoma (pRB) proteins. Both these proteins are products of tumour suppressor genes that normally maintain tightly regulated cell proliferation and growth. When the control mechanisms of the cell cycle are disturbed, unrestricted cell proliferation and ultimately the tumour state occurs.
The purpose of this paper is to explore the extent of pRB and p53 immunoexpression and to see if a relation exists between these two proteins, in the setting of both HPV 16/18 positive and negative cervical cancers from South Africa.
Methods
Fifty consecutive cases diagnosed as carcinoma of the uterine cervix were used in this study. Fresh tissue was collected for DNA extraction and surgical biopsies were also submitted in 10% buffered formalin. All 50 cases were evaluated by two of us (RC and AB) This study has therefore confirmed that p53 protein expression (which is independent of HPV 16/18 status) is low in cervical cancers. pRB immunostaining on the other hand is high, and this too is independent of HPV 16/18 infection. Of interest is the inverse relation between pRB (high) and p53 (low) proteins in cervical cancer. 
